MFS Research International Fund Class C (MRICX) - Foreign Large Blend fund with $17.65 Billion in assets. The fund allocates 23.03% of its portfolio to its top 10 holdings. It primarily invests in averagemarketcap cap stocks , with a focus on the cash and equivalents sector.
The largest holding in the fund is Novo Nordisk A/S at 2.43% of total assets. This is followed by Schneider Electric SE (2.82%) and Linde PLC (1.76%).
| Name | Weight | Owned | Change |
|---|---|---|---|
| Novo Nordisk A/S | 2.43% | - | - |
| Schneider Electric SE | 2.82% | - | - |
| Linde PLC | 1.76% | - | - |
| Roche Holding AG | 3.17% | - | - |
| ASML Holding NV | 2.21% | - | - |
| Hitachi Ltd | 2.45% | - | - |
| Nestle SA | 1.99% | - | - |
| LVMH Moet Hennessy Louis Vuitton SE | 2.08% | - | - |
| TotalEnergies SE | 2.10% | - | - |
| NatWest Group PLC | 2.02% | - | - |
| Barclays PLC | 1.97% | - | - |
| Aon PLC | 1.77% | - | - |
| Euronext NV | 1.91% | - | - |
| British American Tobacco PLC | 1.81% | - | - |
| MFS Institutional Money Market Portfolio | 1.67% | - | - |
| Mizuho Financial Group Inc | 2.90% | - | - |
| Bank of Ireland Group PLC | 1.84% | - | - |
| Taiwan Semiconductor Manufacturing Co Ltd | 2.21% | - | - |
| ABN AMRO Bank NV | 1.61% | - | - |
| Novartis AG | 2.12% | - | - |
| Tokyo Electron Ltd | 1.90% | - | - |
| AstraZeneca PLC | 1.78% | - | - |